Astarte Medical Partners specializes in clinical intelligence solutions aimed at enhancing nutrition and feeding practices in pediatric care, particularly for vulnerable populations such as preterm infants. Their flagship products include NICUtrition®, a real-time clinical decision support tool designed for neonatal intensive care units (NICUs) that monitors and analyzes feeding and nutrition delivery to improve care quality and outcomes. Additionally, NutritionIQ serves as a comprehensive platform that provides hospitals with access to their own feeding and nutrition data, enabling clinicians to make informed decisions, reduce practice variability, and enhance team collaboration. Both technologies aim to alleviate clinical burdens and optimize care protocols, ultimately leading to better health outcomes for pediatric patients.

Another innovative offering from Astarte Medical is NICUbiome™, a digital diagnostic platform that utilizes machine learning to assess gut health in preterm infants. This platform allows for the identification of different gut community types, enabling tailored feeding and intervention strategies that support precision nutrition. By leveraging extensive datasets, NICUbiome™ provides actionable insights and risk stratification, allowing clinical teams to allocate resources effectively and create customized treatment plans. Together, these technologies represent a significant advancement in the delivery of evidence-based care, focusing on improving nutritional outcomes and overall health for infants and children in critical care settings.

United States

Develops a software solution, NICUtrition™, to improve thecare of preterm infants by providing quantitative data about gut health, allowing for personalized care and nutrition to optimize growth and outcomes.

Astarte Medical Partners

Company Details